Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease

  title={Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease},
  author={Emmanouela Kampouraki and Farhad Kamali},
  journal={Expert Review of Clinical Pharmacology},
  pages={789 - 797}
ABSTRACT Introduction: The effectiveness of oral anticoagulation therapy with warfarin (a vitamin K antagonist) in the treatment of thromboembolic disease, including stroke prophylaxis in patients with atrial fibrillation is well recognised. However, warfarin has a narrow therapeutic window and an unpredictable anticoagulation response, which make it difficult to achieve and maintain optimal anticoagulation. Various dietary factors, including sudden changes in eating patterns, can significantly… Expand
Use of New Oral Anticoagulants in Preventing Ischemic Stroke in Patients with Atrial Fibrillation
The clinical presentation of AF is reviewed and the use of warfarin versus NOACs for the prevention of ischemic stroke is compared. Expand
Beliefs related to diet adherence of patients treated with oral anticoagulants.
In the outpatient clinic specializing in oral anticoagulation, patients add more specific beliefs about the interference of vitamin K-rich diet on coagulating, when compared to those in the general cardiology outpatient clinic. Expand
Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department.
The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD-supported patients and the probability of thoseExpand
Crenças relacionadas à adesão a dieta de pacientes tratados com anticoagulantes orais
No ambulatório especializado em anticoagulação oral os pacientes agregam mais crenças específicas acerca da interferência da dieta rica em vitamina K sobre a coagulaça, quando comparados with os do ambulatowrio cardiológico geral. Expand


Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?
Findings from a randomized clinical trial suggest that dietary vitamin K manipulation is a viable option for managing stability of oral anticoagulant therapy and appears to be effective for those patients who are under-anticoagulated and consume a small number of vitamin K-rich food sources. Expand
Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin.
Concomitant supplementation of vitamin K, perhaps through reducing the relative day-to-day variability in dietary vitamin K intake, can significantly improve anticoagulation control in patients with unexplained instability of response to warfarin. Expand
Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation.
Daily supplementation with oral vitamin K in unstable patients could lead to a more stable anticoagulation response to warfarin. Expand
Daily vitamin K supplementation improves anticoagulant stability
Supplementation of vitamin K antagonists with 100 μg vitamin K improves stability of anticoagulant therapy and is likely to reduce the number of bleeding and thrombotic events. Expand
Improved Oral Anticoagulation After a Dietary Vitamin K–Guided Strategy: A Randomized Controlled Trial
A vitamin K–guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR. Expand
Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin.
Long-term anticoagulation effect of warfarin is more stable in the patients who take greater than a certain amount of dietary vitamin K. Expand
Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios
Vitamin K supplementation led to a decrease in INR variability in five of the nine patients studied andINR fluctuations may decrease in selected patients with unstable INRs who receive vitamin K supplementation. Expand
Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols.
The prospective data strengthen the concept that the interaction between vitamin K and coumarin is a clinically relevant, major independent factor that interferes with anticoagulation stability. Expand
Oral anticoagulation therapy in children.
Prospective studies from Canada and Argentina propose guidelines for administering and monitoring warfarin and acenocoumarol therapy in children and highlight the difficulty of their use in pediatric patients. Expand
Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin.
The observed shortening of the prothrombin time in dogs receiving coumarin anticoagulants and reports of a need for an increase in warfarin dose were noted in 2 separate case reports of patients taking vitamin C supplement. Expand